132 related articles for article (PubMed ID: 9330702)
1. Selective proteolytical cleavage of the ligand-binding chains of the IL-2-receptor and IL-6-receptor by neutrophil-derived proteases.
Bank U; Reinhold D; Kunz D; Ansorge S
Adv Exp Med Biol; 1997; 421():231-42. PubMed ID: 9330702
[No Abstract] [Full Text] [Related]
2. Selective proteolytic cleavage of IL-2 receptor and IL-6 receptor ligand binding chains by neutrophil-derived serine proteases at foci of inflammation.
Bank U; Reinhold D; Schneemilch C; Kunz D; Synowitz HJ; Ansorge S
J Interferon Cytokine Res; 1999 Nov; 19(11):1277-87. PubMed ID: 10574621
[TBL] [Abstract][Full Text] [Related]
3. Inactivation of interleukin-6 by neutrophil proteases at sites of inflammation. Protective effects of soluble IL-6 receptor chains.
Bank U; Küpper B; Ansorge S
Adv Exp Med Biol; 2000; 477():431-7. PubMed ID: 10849768
[TBL] [Abstract][Full Text] [Related]
4. IL-6: a regulator of the transition from neutrophil to monocyte recruitment during inflammation.
Kaplanski G; Marin V; Montero-Julian F; Mantovani A; Farnarier C
Trends Immunol; 2003 Jan; 24(1):25-9. PubMed ID: 12495721
[TBL] [Abstract][Full Text] [Related]
5. Differential regulation of neutrophil-activating chemokines by IL-6 and its soluble receptor isoforms.
McLoughlin RM; Hurst SM; Nowell MA; Harris DA; Horiuchi S; Morgan LW; Wilkinson TS; Yamamoto N; Topley N; Jones SA
J Immunol; 2004 May; 172(9):5676-83. PubMed ID: 15100312
[TBL] [Abstract][Full Text] [Related]
6. Interleukin-6 and its receptors: a highly regulated and dynamic system.
Wolf J; Rose-John S; Garbers C
Cytokine; 2014 Nov; 70(1):11-20. PubMed ID: 24986424
[TBL] [Abstract][Full Text] [Related]
7. Inactivation of IL-6 and soluble IL-6 receptor by neutrophil derived serine proteases in cystic fibrosis.
McGreal EP; Davies PL; Powell W; Rose-John S; Spiller OB; Doull I; Jones SA; Kotecha S
Biochim Biophys Acta; 2010; 1802(7-8):649-58. PubMed ID: 20438838
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-6 and chronic inflammation.
Gabay C
Arthritis Res Ther; 2006; 8 Suppl 2(Suppl 2):S3. PubMed ID: 16899107
[TBL] [Abstract][Full Text] [Related]
9. Generation of Soluble Interleukin-11 and Interleukin-6 Receptors: A Crucial Function for Proteases during Inflammation.
Lokau J; Agthe M; Garbers C
Mediators Inflamm; 2016; 2016():1785021. PubMed ID: 27493449
[TBL] [Abstract][Full Text] [Related]
10. Interleukins and the immune system 1.
O'Garra A
Lancet; 1989 Apr; 1(8644):943-7. PubMed ID: 2565429
[No Abstract] [Full Text] [Related]
11. Evidence for a crucial role of neutrophil-derived serine proteases in the inactivation of interleukin-6 at sites of inflammation.
Bank U; Küpper B; Reinhold D; Hoffmann T; Ansorge S
FEBS Lett; 1999 Nov; 461(3):235-40. PubMed ID: 10567703
[TBL] [Abstract][Full Text] [Related]
12. Immunotherapeutic implication of IL-6 blockade.
Tanaka T; Kishimoto T
Immunotherapy; 2012 Jan; 4(1):87-105. PubMed ID: 22150003
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-15 increases neutrophil adhesion onto human respiratory epithelial A549 cells and attracts neutrophils in vivo.
Pelletier M; Girard D
Clin Exp Immunol; 2005 Aug; 141(2):315-25. PubMed ID: 15996196
[TBL] [Abstract][Full Text] [Related]
14. Cutting edge: Foxp3+CD4+CD25+ regulatory T cells induced by IL-2 and TGF-beta are resistant to Th17 conversion by IL-6.
Zheng SG; Wang J; Horwitz DA
J Immunol; 2008 Jun; 180(11):7112-6. PubMed ID: 18490709
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-6, A Cytokine Critical to Mediation of Inflammation, Autoimmunity and Allograft Rejection: Therapeutic Implications of IL-6 Receptor Blockade.
Jordan SC; Choi J; Kim I; Wu G; Toyoda M; Shin B; Vo A
Transplantation; 2017 Jan; 101(1):32-44. PubMed ID: 27547870
[TBL] [Abstract][Full Text] [Related]
16. Circulating Soluble IL-6R but Not ADAM17 Activation Drives Mononuclear Cell Migration in Tissue Inflammation.
Schumacher N; Schmidt S; Schwarz J; Dohr D; Lokau J; Scheller J; Garbers C; Chalaris A; Rose-John S; Rabe B
J Immunol; 2016 Nov; 197(9):3705-3715. PubMed ID: 27698010
[TBL] [Abstract][Full Text] [Related]
17. IL-6 regulates neutrophil trafficking during acute inflammation via STAT3.
Fielding CA; McLoughlin RM; McLeod L; Colmont CS; Najdovska M; Grail D; Ernst M; Jones SA; Topley N; Jenkins BJ
J Immunol; 2008 Aug; 181(3):2189-95. PubMed ID: 18641358
[TBL] [Abstract][Full Text] [Related]
18. Interleukin (IL)-2 and IL-15 have different effects on human natural killer lymphocytes.
Pillet AH; Thèze J; Rose T
Hum Immunol; 2011 Nov; 72(11):1013-7. PubMed ID: 21925225
[TBL] [Abstract][Full Text] [Related]
19. Neutrophil-Derived Proteases Escalate Inflammation through Activation of IL-36 Family Cytokines.
Henry CM; Sullivan GP; Clancy DM; Afonina IS; Kulms D; Martin SJ
Cell Rep; 2016 Feb; 14(4):708-722. PubMed ID: 26776523
[TBL] [Abstract][Full Text] [Related]
20. Gelatinase B/matrix metalloproteinase-9 and other neutrophil proteases switch off interleukin-2 activity.
Rybakin V; Stas M; Ugarte-Berzal E; Noppen S; Vandooren J; Van Aelst I; Liekens S; Proost P; Opdenakker G
Biochem J; 2019 Aug; 476(15):2191-2208. PubMed ID: 31262730
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
